Treatment of Chronic Thromboembolic Pulmonary Hypertension: The Role of Medical Therapy and Balloon Pulmonary Angioplasty
References
- Madani MM, Auger WR, Pretorius V, Pulmonary endarterectomy: Recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg. 2012 July; 94( 1): 97– 103.
- Mayer E, Jenkins D, Lindner J, Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. J Thorac Cardiovasc Surg. 2011 Mar; 141( 3): 702– 10.
- Delcroix M, Lang I, Pepke-Zaba J, Long-term outcome of patients with chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation. 2016 Mar 1; 133( 9): 859– 71.
- Pepke-Zaba J, Delcroix M, Lang I, Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation. 2011 Nov 1; 124( 18): 1973– 81.
- Kim NH, Delcroix M, Jenkins DP, Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62( 25 Suppl): D92– 9.
- Galiè N, Humbert M, Vachiery J-L, 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016 Jan 1; 37( 1): 67– 119.
- Cabrol S, Souza R, Jais X, Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2007 Apr; 26( 4): 357– 62.
- Skoro-Sajer N, Bonderman D, Wiesbauer F, Treprostinil for severe inoperable chronic thromboembolic pulmonary hypertension. J Thromb Haemost. 2007 Mar; 5( 3): 483– 9.
- Olschewski H, Simonneau G, Galiè N, Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002 Aug 1; 347( 5): 322– 9.
- Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration. 2008 Aug; 76( 2): 154– 9.
- Suntharalingam J, Treacy CM, Doughty NJ, Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008 Aug; 134( 2): 229– 36.
- Reichenberger F, Voswinckel R, Enke B, Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Resp J. 2007 Nov; 30: 922– 7.
- Jais X, D'Armini AM, Jansa P, Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNoperable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008 Dec 16; 52( 25): 2127– 34.
- Becattini C, Manina G, Busti C, Gennarini S, Agnelli G. Bosentan for chronic thromboembolic pulmonary hypertension: Findings from a systematic review and meta-analysis. Thromb Res. 2010 Jul; 126( 1): e51– 6.
- ClinicalTrials.gov [Internet]. Bethesda, MD: U.S. National Institutes of Health. Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (MERIT-1); 2013 Dec 20 [cited 2016 Sep 29]. Available from: https://clinicaltrials.gov/ct2/show/nct02021292.
- Ghofrani HA, D'Armini AM, Grimminger F, Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013 Jul 25; 369( 4): 319– 29.
- Simonneau G, D'Armini AM, Ghofrani H-A, Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: Data from the chest-2 open-label, randomised, long-term extension trial. Lancet Resp Med. 2016 May; 4( 5): 372– 80.
- Scholzel BE, Post MC, Thijs Plokker HW, Snijder RJ. Clinical worsening during long-term follow-up in inoperable chronic thromboembolic pulmonary hypertension. Lung. 2012 Apr; 190: 161– 7.
- Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg. 2005 Dec; 28( 6): 882– 8.
- Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet. 1991 Nov 9; 338( 8776): 1173– 4.
- Gårdebäck M, Larsen FF, Rådegran K. Nitric oxide improves hypoxaemia following reperfusion oedema after pulmonary thromboendarterectomy. Br J Anaesth. 1995 Dec; 75( 6): 798– 800.
- Bonderman D, Skoro-Sajer N, Jakowitsch J, Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007 Apr 24; 115( 16): 2153– 8.
- Freed DH, Thomson BM, Berman M, Survival after pulmonary thromboendarterectomy: Effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg. 2011 Feb; 141( 2): 383– 7.
- Cannon JE, Su L, Kiely DG, Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: Results from the United Kingdom national cohort. Circulation. 2016 May 3; 133( 18): 1761– 71.
- Darteville P, Fadel E, Mussot S, Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004 Apr; 23( 4): 637– 48.
- Fernandes TM, Poch DS, Papamatheakis DG, Pre-operative use of pulmonary arterial hypertension-targeted medication and the effects on post-pulmonary endarterectomy morbidity and mortality. J Heart Lung Transplant. 2015 Apr; 34( 4, Supplement): S159.
- Nagaya N, Sasaki N, Ando M, Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest. 2003 Feb; 123( 2): 338– 43.
- Reesink HJ, Surie S, Kloek JJ, Bosentan as a bridge to pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2010 Jan; 139( 1): 85– 91.
- Surie S, Reesink HJ, Marcus T, Bosentan treatment is associated with improvement of right heart ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Clin Cardiol. 2013 Nov; 36( 11): 698– 703.
- Jensen KW, Kerr KM, Fedullo PF, Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009 Sep 29; 120( 13): 1248– 54.
- Delcroix M, Lang I, Pepke-Zaba J, Long-term outcome of patients with chronic thromboembolic pulmonary hypertension. Results from an International Prospective Registry. Circulation. 2016 Mar 1; 133( 9): 859– 71.
- Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988 Dec; 94( 6): 1249– 53.
- Feinstein JA, Goldhaber SZ, Lock JE, Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001 Jan 2; 103( 1): 10– 3.
- Mizoguchi H, Ogawa A, Munemasa M, et. al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012 Dec; 5( 6): 748– 55.
- Kataoka M, Inami T, Hayashida K, Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012 Dec; 5( 6): 756– 62.
- Sugimura K, Fukumoto Y, Satoh K, Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012; 76( 2): 485– 8.
- Andreassen AK, Ragnarsson A, Gude E, Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013 Oct; 99( 19): 1415– 20.
- Hosokawa K, Abe K, Oi K, Mukai Y, Hirooka Y, Sunagawa K. Negative acute hemodynamic response to balloon pulmonary angioplasty does not predicate the long-term outcome in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2015 Jun 1; 188: 81– 3.
- Ogawa A, Matsubara H. Balloon pulmonary angioplasty: A treatment option for inoperable patients with chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med. 2015 Feb 17; 2: 4.
- Kitani M, Ogawa A, Sarashina T, Yamadori I, Matsubara H. Histological changes of pulmonary arteries treated by balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2014 Dec; 7( 6): 857– 9.
- Kimura M, Kohno T, Kawakami T, Balloon pulmonary angioplasty attenuates ongoing myocardial damage in patients with chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2016 Mar 15; 207: 387– 9.
- Roik M, Wretowski D, Łabyk A, Refined balloon pulmonary angioplasty driven by combined assessment of intra-arterial anatomy and physiology--Multimodal approach to treated lesions in patients with non-operable distal chronic thromboembolic pulmonary hypertension--Technique, safety and efficacy of 50 consecutive angioplasties. Int J Cardiol. 2016 Jan 15; 203: 228– 35.
- Shimura N, Kataoka M, Inami T, Additional percutaneous transluminal pulmonary angioplasty for residual or recurrent pulmonary hypertension after pulmonary endarterectomy. Int J Cardiol. 2015 Mar 15; 183: 138– 42.
- Taniguchi Y, Miyagawa K, Nakayama K, Balloon pulmonary angioplasty: An additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014 Aug; 10( 4): 518– 25.
- Inami T, Kataoka M, Shimura N, Pulmonary edema predictive scoring index (PEPSI), a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty. JACC Cardiovasc Interv. 2013 Jul; 6( 7): 725– 36.
- Ikeda N, Kubota S, Okazaki T, Comparison of intravascular optical frequency domain imaging versus intravascular ultrasound during balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Catheter Cardiovasc Interv. 2016 Jun; 87( 7): E268– 74.
- Jorge E, Baptista R, Calisto J, Optical coherence tomography of the pulmonary arteries: A systematic review. J Cardiol. 2016 Jan; 67( 1): 6– 14.
- Inami T, Kataoka M, Shimura N, Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: A breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc Interv. 2014 Nov; 7( 11): 1297– 1306.
- Inohara T, Kawakami T, Kataoka M, Lesion morphological classification by OCT to predict therapeutic efficacy after balloon pulmonary angioplasty in CTEPH. Int J Cardiol. 2015 Oct 15; 197: 23– 5.
- Wiedenroth CB, Liebetrau C, Breithecker A, Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant. 2016 May; 35( 5): 591– 6.
DOI: https://doi.org/10.14797/mdcj-12-4-205 | Journal eISSN: 1947-6108
Language: English
Page range: 205 - 212
Published on: Oct 1, 2016
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2016 Timothy M. Fernandes, David S. Poch, William R. Auger, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.